UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Investment Research • Mar 13, 2026

UnitedHealth Group Incorporated (UNH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

UnitedHealth Group Incorporated (UNH) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Seeking Alpha • Mar 12, 2026

U.S. senator Markwayne Mullin just made a super suspicious stock trade

Markwayne Mullin, American politician serving as Oklahoma's junior United States senator, has filed a new Periodic Transaction Report, revealing a rather suspicious joint stock purchase.

Finbold • Mar 11, 2026

UnitedHealth Group (UNH) Advances While Market Declines: Some Information for Investors

UnitedHealth Group (UNH) closed the most recent trading day at $285.25, moving +1.03% from the previous trading session.

Zacks Investment Research • Mar 11, 2026

Harbor Health Care ETF Q4 2025 Portfolio Review

Revolution Medicines was a top contributor during the quarter. AbbVie, by contrast, traded largely sideways, as investors continued to assess its post-patent earnings durability. While Eli Lilly delivered strong absolute performance — driven by continued GLP-1 demand and the FDA approval of Zepbound — our underweight position in the name was a significant detractor from relative results. During the quarter, we purchased Avidity Biosciences, a clinical-stage biopharma company focused on RNA therapies for rare muscle diseases, and Abivax SA, a clinical-stage biopharma company focused on chronic inflammatory diseases.

Seeking Alpha • Mar 11, 2026

4 HMO Stocks to Watch Despite Escalating Costs, Nursing Shortage

The Medical-HMO industry leverages technology capabilities and M&A to fuel growth. Yet rising medical costs, workforce shortages and policy shifts pose roadblocks.

Zacks Investment Research • Mar 11, 2026

Healthcare Jobs Drop, UnitedHealth Stock Slips: Opportunity or Risk?

UNH faces rising medical costs, regulatory probes and a healthcare hiring slump while shares keep falling, leaving investors weighing risk or opportunity.

Zacks Investment Research • Mar 9, 2026

UNH Deploys AI in Optum Rx to Tackle Pharmacy Fraud and Cost Leakage

UnitedHealth rolls out AI in Optum Rx to flag pharmacy fraud, billing anomalies and medication risks, aiming to curb cost leakage and improve compliance.

Zacks Investment Research • Mar 9, 2026

UNITEDHEALTH GROUP INCORPORATED INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates UnitedHealth Group Incorporated's Directors and Officers for Breach of Fiduciary Duties – UNH

NEW YORK--(BUSINESS WIRE)---- $UNH #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of UnitedHealth Group Incorporated (NYSE: UNH) failed to manage UnitedHealth Group in an acceptable manner, breaching their fiduciary duties to UnitedHealth Group, and whether UnitedHealth Group and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On February 16, 2.

Business Wire • Mar 3, 2026

Here's Why UnitedHealth Group (UNH) Fell More Than Broader Market

The latest trading day saw UnitedHealth Group (UNH) settling at $289.21, representing a -1.94% change from its previous close.

Zacks Investment Research • Mar 3, 2026